Posted by Michael Wonder on 23 Feb 2023
US Medicare says no change to Alzheimer's drug restrictions
23 February 2023 - The US Government health plan for people over the age of 65 on Wednesday said it would not reconsider strict coverage limits put in place last year for new Alzheimer's treatments, rejecting a request from the Alzheimer's Association.
The Centers for Medicare and Medicaid Services reaffirmed its policy allowing coverage for drugs designed to clear amyloid plaques from the brains of Alzheimer's patients only if a medication is approved under the FDA's standard review process, not under its accelerated review program.
